The Changing Landscape of Immunotherapy for Advanced Renal Cancer
Author:
Publisher
Elsevier BV
Subject
Urology
Reference140 articles.
1. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2;Bukowski;Cancer,1997
2. Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial. Medical Research Council Renal Cancer Collaborators;Lancet,1999
3. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007
4. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2007
5. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial;Motzer;Lancet,2008
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy for renal cell carcinoma: New therapeutic combinations and adverse event management strategies: A review;Medicine;2024-07-26
2. A causal link between circulating leukocytes and three major urologic cancers: a mendelian randomization investigation;Frontiers in Genetics;2024-06-19
3. Emerging Novel Functional Imaging and Immunotherapy in Renal Cell Carcinoma and Current Treatment Sequencing Strategies After Immunotherapy;American Society of Clinical Oncology Educational Book;2024-06
4. Therapeutic options for different metastatic sites arising from renal cell carcinoma: A review;Medicine;2024-05-24
5. Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes;Cancer Cell;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3